Immunomodulator OM 163-induced reversal of tumor-mediated immunosuppression and downregulation of TGF-β1 in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 2, 1996, Pages 926-933

  Lagadec, Patricia ^a   Reveneau, Sylvie ^a   Lejeune, Pascale ^a   Pinard, Dominique ^a   Borman, Ton ^b   Bauer, Jacques ^c   Jeannin, Jean François ^a  

^a PSL RESEARCH UNIVERSITY   (France)

^b TNO   (Netherlands)

^c OM Laboratories   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 2; MESSENGER RNA; OM 163; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; FEMALE; IMMUNE DEFICIENCY; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TUMOR CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ESCHERICHIA COLI; GENE EXPRESSION; IMMUNOSUPPRESSION; LYMPHOCYTES; RATS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030426809     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. + T cells. Nature (Lond.) 372: 691-694, 1994.
2. BESNARD, P., BERNARD, A. AND CARTIER, H.: Quantification des ARNm codant pour les fatty acid binding proteins (FABP) entérocytaires de rat: Effet d'un régime hyperlipidique et du jeûne. CR Acad. Sci. 312: 407-413, 1991.
3. BOST, L. K., BIELIGK, S. C. AND JAFFE, B. M.: Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies. J. Immunol. 154: 718-729, 1995.
4. CAIGNARD, A., PELLETIER, H. AND MARTIN, F.: Specificity of the immune response leading to protection or enhancement by regressive and progressive variants of a rat colon carcinoma. Int. J. Cancer 42: 883-886, 1988.
5. CASTILLA, A., PRIETO, J. AND FAUSTO, N.: Transforming growth factor-β1 and α in chronic liver disease: Effects of interferon-α therapy. N.E. J. Med. 324: 933-940, 1991.
6. CHIRGWIN, J. M., PRZYBYLA, A. E., MACDONALD, R. J. AND RUTTER, W. J.: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979.
7. DHANANI, S., HUANG, M., WANG, J. AND DUBINETT, S. M.: Interferon-α inhibits murine macrophage transforming growth factor-β mRNA expression. Inflammation 18: 301-309, 1994.
8. DUBINETT, S. M., HUANG, M., DHANANI, S., WANG, J. AND BEROIZA, T.: Down-regulation of macrophage transforming growth factor-β messenger RNA expression by IL-7. J. Immunol. 151: 6670-6680, 1993.
9. DUPUY D'ANGEAC, A., DORNAND, J., EDMONDS-ALT, X., JULLIEN, P., GARCIA-SANZ, J. AND ERARD, F.: Transforming growth factor type beta 1 (TGF-β1) down-regulates interleukin-2 production and up-regulates interleukin-2 receptor expression in a thymoma cell line. J. Cell. Physiol. 147: 460-469, 1991.
10. DUREZ, P., ABRAMOWICZ, D., GERARD, C., VAN MECHELEN, M., AMRAOUI, Z., DUBOIS, C., OBERDAN, L., VELU, T. AND GOLDMAN, M.: In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: Differential modulation by cyclosporin A. J. Exp. Med. 177: 551-555, 1993.
11. DYE, E. S. AND NORTH, R. J.: T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P 815 mastocytoma and its metastases. J. Exp. Med. 154: 1033-1042, 1981.
12. EBERT, E. C., ROBERTS, A. J., DEVEREUX, D. AND NAGASE, H.: Selective immunosuppressive action of a factor produced by colon cancer cells. Cancer Res. 50: 6158-6161, 1990.
13. EDWARDS, D. R. AND HEATH, J. K: Regulation of transcription by Transforming growth factor-β. In The Hormonal Control Regulation of Gene Transcription, ed. by P. Cohen and J. G. Foulkes, pp. 333-347, Elsevier Sciences Publisher, New York, 1991.
14. FOX, E., FORD, H. C., DOUGLAS, R., CHERIAN, S. AND NOWELL, P. C.: Evidence that TGF-β can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms. Cell. Immunol. 150: 45-58, 1993.
15. GASTL, G. A., ABRAMS, J. S., NANUS, D. M., OOSTERKAMP, R., SILVER, J., LIU, F., CHEN, M., ALBINO, A. P. AND BANDER, N. H.: Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer 55: 96-101, 1993.
16. GATELY, M., DESAI, B. B., WOLITZKI, A. G., QUINN, P. M., DWYER, C. M., PODLASKI, F. J., FAMILETTY, C., SINIGAGLIA, F., CHIZONNITE, R., GUBLER, V. AND STERN, A. S.: Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147: 874-882, 1992.
17. GRÉGOIRE, M., GARRIGUE, L., BLOTTIÈRE, H. M., DENIS, M. G. AND MEFLAH, K.: Possible involvement of TGF-β1 in the distinct tumorigenic properties of two rat colon carcinoma clones. Invasion & Metastasis 12: 185-196, 1992.
18. GROTENDORST, G. R., SMALE, G. AND PENCEV, D.: Production of transforming growth factor-β by human peripheral blood monocytes and neutrophils. J. Cell. Physiol. 140: 396-402, 1989.
19. IOANNIDES, C. G. AND WHITESIDE, T. L.: T cell recognition of human tumors: Implications for molecular immunotherapy of cancer. Clin. Immunol. Immunopathol. 66: 91-106, 1993.
20. JHAN, B., BRIEGER, J., FENCHEL, K., MITROU, P. S. AND BERGMANN, L.: In vivo regulation of TGF-β1 transcription by immunotherapy: Interleukin-2 impairs interferon-α-stimulated increase in steady state mRNA levels of transforming growth factor-β1. Cancer Immunol. Immunother. 38: 304-310, 1994.
21. JIMBO, T., AKIMOTO, T. AND TOHGO, A.: Effect of combined administration of a synthetic low toxicity lipid A derivative, DT-5461a, and indomethacin in various experimental tumor models of colon 26 carcinoma in mice. Cancer Immunol. Immunother. 40: 10-16, 1995.
22. KAMBAYASHI, T., ALEXANDER, H. R., FONG, M. AND STRASSMANN, G.: Potential involvement of IL-10 in suppressing tumor-associated macrophages. J. Immunol. 164: 3383-3390, 1995.
23. KEMENY, N., LOKICH, J. J., ANDERSON, N. AND AHLGHEN, J. D.: Recent advances in the treatment of advanced colorectal cancer. Cancer 71: 9-18, 1993.
24. + T cell. Immunol. Today 15: 107-110, 1994.
25. LAHM, H. AND ODARTCHENKO, N.: Role of transforming growth factor-β in colorectal cancer. Growth Factors 9: 1-9, 1993.
26. LEHNER, B., SCHLAG, P., LIEBRICH, W. AND SCHIRMACHER, V.: Post-operative active specific immunization in resected colorectal cancer patients with a virus modified autologous tumor cell vaccine. Cancer Immunol. Immunother. 32: 173-178, 1990.
27. MACCUBIN, D. L., MACE, K. F., EHRKE, M. J. AND MIHICH, E.: Modification of host antitumor defense mechanisms in mice in progressively growing tumor. Cancer Res. 49: 4216-4224, 1989.
28. MAEGER, A.: Assays for transforming growth factor-β. J. Immunol. Methods 141: 1-14, 1991.
29. MARTIN, F., CAIGNARD, A., JEANNIN, J. F., LECLERC, A. AND MARTIN, M. S.: Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int. J. Cancer 32: 623-627, 1983.
30. MARTIN, M. S., MARTIN, F., MICHIELS, R., BASTIEN, H., JUSTRABO, E., BORDES, M. AND VIRY, B.: An experimental model for cancer of the colon and rectum. Digestion 8: 22-34, 1973.
31. MARTYRE, M. C., MAGDELENAT, H. AND CALVO, F.: Interferon-γ in vivo reverses the increased platelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia. Br. J. Haematol. 77: 431-435, 1991.
32. MATTERN, T., THANHAUSER, A., REILING, N., TOELLNER, K. M., DUCHROW, M., KUSUMOTO, S., RIETSCHEL, E. T., ERNST, M., BRADE, H., FLAD, H. D. AND ULMER, A. J.: Endotoxin and lipid A stimulate the proliferation of human T cells in the presence of autologous monocytes. J. Immunol. 163: 2996-3004, 1994.
33. MIESHER, S., WHITESIDE, T. L., CARREL, S. AND VON FLIEDNER, V.: Functional properties of tumor infiltrating and blood lymphocytes in patients with solid tumors: Effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J. Immunol. 136: 1899-1907, 1986.
34. MILLER-GRAZIANO, C. L., ZHU, D. AND KODYS, K.: Differential induction of human monocyte transforming growth factor-β1 production and its regulation by interleukin-4. J. Clin. Immunol. 14: 61-72, 1994.
35. + T cell responsiveness in the tumor-bearing state and its recovery in in vitro culture free of tumor burden. Jpn. J. Cancer Res. 84: 1181-1189, 1993.
36. OLSSON, N. O., CAIGNARD, A., MARTIN, M. S. AND MARTIN, F.: Effect of indomethacin on the growth of colon cancer cells in syngeneic rats. Int. J. Immunopharmacol. 6: 329-334, 1984.
37. ONIER, N., LEJEUNE, P., MARTIN, M., HAMMANN, A., BAUER, J., HIRT, P., LAGADEC, P. AND JEANNIN, J. F.: Involvement of T lymphocytes in curative effect of a new immunomodulator OM 163 on rat colon cancer metastases. Eur. J. Cancer. 29A: 2003-2009, 1993.
38. - large granular lymphocyte functions. J. Immunol. 146: 3791-3798, 1991.
39. REISSER, D., OLSSON, N. O. AND MARTIN, F.: In vivo and in vitro reactivity of rat spleen cells against regressor and progressor colon-cancer cell variants. Int. J. Cancer 53: 651-656, 1993.
40. RITA, M. AND YOUNG, I.: Eicosanoids and the immunology of cancer. Cancer Metastasis Rev. 13: 337-348, 1994.
41. ROSZMAN, T., ELLIOTT, L. AND BROOKS, W.: Modulation of T-cell function by gliomas. Immunol. Today 12: 370-374, 1991.
42. RUEGEMER, J. J., HO, S. N., AUGUSTINE, J. A., SCHLAGER, J. W., BELL, M. P., MCKEAN, D. J. AND ABRAHAM, R. T.: Regulatory effects of transforming growth factor-β on IL-2- and IL-4-dependent T cell-cycle progression. J. Immunol. 144: 1767-1776, 1990.
43. RUSCETTI, F., VARESIO, L., OCHOA, A. AND ORTALDO, J.: Pleiotropic effects of transforming growth factor-β on cells of the immune system. Annu. N.Y. Acad. Sci. 685: 450-488, 1993.
44. SPORN, M. B. AND ROBERTS, A. B.: Transforming growth factor-β: Multiple actions and potential clinical applications. J. Am. Med. Assoc. 262: 938-941, 1989.
45. TAIPALE, J., KOLI, K. AND KESKI-OJA, J.: Release of transforming growth factor-β1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J. Biol. Chem. 267: 25378-25384, 1992.
46. VAN DEN EYNDE, B., LETHE, B., VAN POL, A., DE PLAEN, E. AND BOON, T.: The gene encoding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 173: 1373-1384, 1991.
47. VAN VLASSEELAER, P., BORREMANS, B., VAN GORP, U., DASCH, J. R. AND DE WAAL-MALEFYT, R.: Interleukin-10 inhibits transforming growth factor-β (TGF-β) synthesis required for osteogenic commitment of mouse bone marrow cells. J. Cell. Biol. 124: 569-577, 1994.
48. YAMAMOTO, N., ZOU, J. P., LI, X. F., TAKENADA, H., NODA, S., FUJII, J., ONO, S., KOBAYASHI, Y., MUKAIDA, N., MATSUSHIMA, K., FUJIWARA, H. AND HAMAOKA, T.: Regulatory mechanisms for production of IFN-γ and TNF-α by antitumor T cells or macrophages in the tumor-bearing state. J. Immunol. 154: 2281-2290, 1995.
49. ZUBER, P., KUPPNER, M. C. AND DE TRIBOLET, N.: Transforming growth factor-β2 down-regulates HLA-DR antigen expression on human malignant glioma cells. Eur. J. Immunol. 18: 1623-1626, 1988.